Intraoperative visualization of residual tumor: The role of perfusion-weighted imaging in a high-field intraoperative magnetic resonance scanner

Neurosurgery

Volumn 72, Issue , 2013, Pages

  Roder, Constantin ^a   Bender, Benjamin ^a   Ritz, Rainer ^a   Honegger, Jürgen ^a   Feigl, Günther ^a   Naegele, Thomas ^a   Tatagiba, Marcos Soares ^a   Ernemann, Ulrike ^a   Bisdas, Sotirios ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Glioma; Intraoperative magnetic resonance imaging; Perfusion weighted magnetic resonance imaging

Indexed keywords

ARTICLE; BLOOD BRAIN BARRIER; BLOOD VOLUME; CANCER SURGERY; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; GLIOMA; HUMAN; IMAGE PROCESSING; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; MINIMAL RESIDUAL DISEASE; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STANDARD; WHITE MATTER;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEOPLASM, RESIDUAL; NEURONAVIGATION;

EID: 84879690711     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318277c606     Document Type: Article

References (29)

1. Black PM, Alexander E 3rd, Martin C, et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery. 1999;45(3):423-431; discussion 431-433.
2. Steinmeier R, Fahlbusch R, Ganslandt O, et al. Intraoperative magnetic resonance imaging with the Magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery. 1998;43(4):739-747; discussion 747-748.
3. Nimsky C, Ganslandt O, von Keller B, Fahlbusch R. Preliminary experience in glioma surgery with intraoperative high-field MRI. Acta Neurochir Suppl. 2003;88: 21-29.
4. Kuhnt D, Ganslandt O, Schlaffer SM, Buchfelder M, Nimsky C. Quantification of glioma removal by intraoperative high-field magnetic resonance imaging: an update. Neurosurgery. 2011;69(4):852-862; discussion 862-863.
5. Keles GE. Intracranial neuronavigation with intraoperative magnetic resonance imaging. Curr Opin Neurol. 2004;17(4):497-500.
6. Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R. Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5.T MRI. Neurol Res. 2006;28(5):482-487.
7. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol. 2004;25(5):746-755.
8. Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? AJNR Am J Neuroradiol. 2009;30(4):681-688.
9. Mangla R, Singh G, Ziegelitz D, et al. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. Radiology. 2010;256(2):575-584.
10. Barajas RF Jr, Chang JS, Segal MR, et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2009;253(2):486-496.
11. Chen X, Xu BN, Meng X, Zhang J, Yu X, Zhou D. Dual-room 1.5-T intraoperative magnetic resonance imaging suite with a movable magnet: implementation and preliminary experience. Neurosurg Rev. 2012;35(1):95-109; discussion 109-110.
12. Jackson A. Analysis of dynamic contrast enhanced MRI. Br J Radiol. 2004;77(spec no 2):S154-S166.
13. Donahue KM, Krouwer HG, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med. 2000;43(6):845-853.
14. McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110(1):156-162.
15. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-764; discussion 264-266.
16. Hatiboglu MA, Weinberg JS, Suki D, et al. Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurgery. 2009;64(6):1073-1081; discussion 1081.
17. Schneider JP, Trantakis C, Rubach M, et al. Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme: a quantitative radiological analysis. Neuroradiology. 2005;47(7):489-500.
18. Nimsky C, Fujita A, Ganslandt O, Von Keller B, Fahlbusch R. Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging. Neurosurgery. 2004;55(2):358-370; discussion 370-371.
19. Sun GC, Chen XL, Zhao Y, et al. Intraoperative high-field magnetic resonance imaging combined with fiber tract neuronavigation-guided resection of cerebral lesions involving optic radiation. Neurosurgery. 2011;69(5):1070-1084; discussion 1084.
20. Roberts TP, Liu F, Kassner A, Mori S, Guha A. Fiber density index correlates with reduced fractional anisotropy in white matter of patients with glioblastoma. AJNR Am J Neuroradiol. 2005;26(9):2183-2186.
21. Stadlbauer A, Nimsky C, Gruber S, et al. Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol. 2007;28(3):462-469.
22. Lupo JM, Cha S, Chang SM, Nelson SJ. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005;26(6):1446-1454.
23. Saraswathy S, Crawford FW, Lamborn KR, et al. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol. 2009;91(1):69-81.
24. Tumors of the Central Nervous System, Volume 5: Astrocytomas, Hemangioblastomas, and Gangliogliomas. 1st ed. New York, NY: Springer Berlin Heidelberg; 2011.
25. Crawford FW, Khayal IS, McGue C, et al. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM. J Neurooncol. 2009;91(3):337-351.
26. Catalaa I, Henry R, Dillon WP, et al. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed. 2006;19(4):463-475.
27. Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology. 2008;249(2):601-613.
28. Cha S, Lupo JM, Chen MH, et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2007;28(6):1078-1084.
29. Wang Y, Alkasab TK, Narin O, et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology. 2011;260(1):105-111.